HHS: Harte Hanks, Inc P/E multiplikatori

Harte Hanks, Inc - HHS emitenti grafik logotipi

Harte Hanks, Inc. (HHS) uchun narxlar tarixi -6.10 miqdoridagi PE koeffitsiyentini aks ettiradi. Harte Hanks, Inc. (HHS) inson resurslarini boshqarishga tizimli yondashuvni joriy qilish orqali asosiy tahlilchilar va raqamli strategistlarni yo'qotish xavfini samarali yumshatadi. Biznes turli bozorlarda tovarlarning integratsiyalashgan targ'iboti va yetkazib berish orqali daromad keltiradi hamda daromad barqarorligini ta'minlash uchun uzoq muddatli kelishuvlardan foydalanadi. Omnikanal yondashuvi jismoniy pochta jo'natmalarini ma'lumotlar bilan integratsiyalashtirib, mijozlarni saqlab qolish uchun mustahkam vositani yaratadi.

HHS: Harte Hanks Narxning foydaga nisbati 04.07.2022 - 16.11.2026

Harte Hanks, Inc (HHS) kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:Harte Hanks - HHS
Harte-Hanks original mahsuloti

Harte Hanks, Inc. (HHS) operatsion barqarorligining baholanishi investitsiyalarning qoplanish muddati va bozor kutuvlari darajasini belgilovchi narx-foyda koeffitsiyentiga asoslanadi. Ushbu P/E koeffitsiyenti marketing platformasining ko'lami va uning shartnomalari xavfsizligi uchun premiumni aks ettiradi, bu esa investorlarga biznes qiymatini qat'iy ma'lumotlar tartibga solish xavflari bilan solishtirib baholash imkonini beradi.

Muhim raqobatchilar

CTAS: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti TRI (Thomson Reuters Corp)|P/E multiplikatori Houlihan Lokey, Inc. (HLI)|Booz Allen Hamilton Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati RTO (rentokil-initial.com)|EXLS: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati PJT Partners Inc PJT|MC (Moelis & Company Group) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati FTI Consulting, Inc. (FCN)|Narxning foydaga nisbati Concentrix Corp|Kapitalizatsiyaning foydaga nisbati Exponent EXPO|Narxning foydaga nisbati WNS Holdings (WNS)|CBZ (CBIZ) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ABM (ABM Industries)|TIC - Narx-foyda koeffitsiyenti|LZ - Narxning foydaga nisbati|ICF International, Inc. (ICFI) - Narx-foyda koeffitsiyenti|TASK: P/E multiplikatori|WLDN - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati CRA International, Inc.|Narx-foyda multiplikatori TIXT (TELUS International Inc)|P/E multiplikatori DLX|performantcorp.com (PHLT) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|The Hackett Group, Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati IBEX Corp (IBEX)|Rich Sparkle Corp - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati XRX (Xerox Corporation)|Conduent (CNDT) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti kingsway-financial.com KFS|INV (Innventure Group) - P/E multiplikatori|Narx-foyda multiplikatori LPRO (Open Lending Corp)|Narx-foyda koeffitsiyenti RCMT (RCM Technologies, Inc.)|TTEC (TTEC Holdings) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori RGP (Resources Connection)|Bozor narxining sof foydaga nisbati EGG (Enigmatig Limited)|TISI - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati PMEC (Primech Holdings Limited)|ACCESS Newswire Inc (ACCS) - Narxning foydaga nisbati|rYojbaba Co Ltd (RYOJ) - P/E multiplikatori|Narxning foydaga nisbati Simpple Ltd.|GRNQ: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Top KingWin (WAI)|QH - Kapitalizatsiyaning foydaga nisbati|Powell Max Limited - Narx-foyda koeffitsiyenti|LICN: Narx-foyda multiplikatori|BMHL - Narxning foydaga nisbati|Zenta Group (ZGM) - Narx-foyda koeffitsiyenti|FOFO: P/E multiplikatori|ARC - Biznesning o‘zini qoplash muddati|GVP (gses.com) - P/E multiplikatori|Narx-foyda koeffitsiyenti NV5 Global, Inc. (NVEE)|P/E multiplikatori PFMT|STER (Sterling Check) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori TDCX (TDCX Inc.)